T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 18.68% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Peloton Interactive
PTON
$2.44B
| $7.44M | ﹤0.01% |
+280,338
| New | +$7.8M |
|
1277
STRATTEC Security
STRT
$338M
| $7.43M | ﹤0.01% |
513,548
+210,858
| +70% | +$4.36M |
|
1278
Arch Capital
ACGL
$33.2B
| $7.35M | ﹤0.01% |
258,283
+14,712
| +6% | +$596K |
|
|
EXPR
1279
DELISTED
Express, Inc.
EXPR
| $7.3M | ﹤0.01% |
244,920
+15,630
| +7% | +$1.15M |
|
|
SFIX
1280
Stitch Fix
SFIX
$487M
| $7.29M | ﹤0.01% |
574,029
-9,760
| -2% | -$212K |
|
1281
Leggett & Platt
LEG
$1.29B
| $7.2M | ﹤0.01% |
270,023
+21,678
| +9% | +$902K |
|
|
BLU
1282
DELISTED
BELLUS Health Inc.
BLU
| $7.19M | ﹤0.01% |
+720,434
| New | +$6.42M |
|
1283
Xerox
XRX
$412M
| $7.13M | ﹤0.01% |
376,243
+30,203
| +9% | +$959K |
|
1284
Timken Company
TKR
$9.03B
| $7.06M | ﹤0.01% |
218,414
+182,163
| +503% | +$8.62M |
|
|
USX
1285
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $6.98M | ﹤0.01% |
2,089,881
+349,373
| +20% | +$1.69M |
|
1286
Invesco
IVZ
$14.3B
| $6.95M | ﹤0.01% |
764,999
+65,022
| +9% | +$988K |
|
1287
Lumentum
LITE
$78B
| $6.93M | ﹤0.01% |
94,087
-4,368
| -4% | -$344K |
|
1288
AngioDynamics
ANGO
$647M
| $6.92M | ﹤0.01% |
663,325
+30,988
| +5% | +$389K |
|
1289
DXC Technology
DXC
$1.79B
| $6.79M | ﹤0.01% |
520,190
+32,535
| +7% | +$860K |
|
|
CCXI
1290
DELISTED
ChemoCentryx, Inc.
CCXI
| $6.75M | ﹤0.01% |
167,964
+76,364
| +83% | +$3.24M |
|
1291
Inogen
INGN
$154M
| $6.64M | ﹤0.01% |
128,620
-3,764
| -3% | -$181K |
|
1292
New Oriental
EDU
$8.49B
| $6.61M | ﹤0.01% |
61,073
+53,473
| +704% | +$6.87M |
|
1293
OGE Energy
OGE
$9.69B
| $6.6M | ﹤0.01% |
214,844
-18,884
| -8% | -$764K |
|
1294
Unum
UNM
$14.7B
| $6.44M | ﹤0.01% |
428,830
+40,377
| +10% | +$971K |
|
1295
Warner Bros
WBD
$69.6B
| $6.39M | ﹤0.01% |
328,495
+53,852
| +20% | +$1.48M |
|
1296
Culp Inc
CULP
$43.8M
| $6.36M | ﹤0.01% |
864,160
-111,594
| -11% | -$1.21M |
|
|
ESPR
1297
DELISTED
Esperion Therapeutics
ESPR
| $6.33M | ﹤0.01% |
200,842
+157,446
| +363% | +$8.31M |
|
|
SFE
1298
DELISTED
Safeguard Scientifics, Inc.
SFE
| $6.28M | ﹤0.01% |
1,131,813
+233,801
| +26% | +$2.09M |
|
|
WW
1299
DELISTED
WW International
WW
| $6.27M | ﹤0.01% |
370,857
+5,987
| +2% | +$186K |
|
1300
Copa Holdings
CPA
$6.14B
| $6.27M | ﹤0.01% |
138,434
+18,677
| +16% | +$1.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.